Altimmune, Inc. (ALT)
NASDAQ: ALT · Real-Time Price · USD
4.230
+0.360 (9.30%)
At close: Jul 1, 2025, 4:00 PM
4.170
-0.060 (-1.42%)
After-hours: Jul 1, 2025, 7:59 PM EDT
Altimmune Stock Forecast
Stock Price Forecast
The 6 analysts that cover Altimmune stock have a consensus rating of "Strong Buy" and an average price target of $20.2, which forecasts a 377.54% increase in the stock price over the next year. The lowest target is $12 and the highest is $26.
Price Target: $20.2 (+377.54%)
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Altimmune stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jan '25 | Feb '25 | Mar '25 | Apr '25 | May '25 | Jun '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 4 | 4 | 4 | 4 | 4 | 4 |
| Buy | 2 | 2 | 2 | 2 | 2 | 1 |
| Hold | 2 | 2 | 2 | 2 | 2 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 8 | 8 | 8 | 8 | 8 | 6 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $12 | Strong Buy | Reiterates | $12 | +183.69% | Jun 27, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $12 | Strong Buy | Reiterates | $12 | +183.69% | Apr 3, 2025 |
| Citizens Capital Markets | Citizens Capital Markets | Buy Reiterates $25 | Buy | Reiterates | $25 | +491.02% | Apr 2, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $12 | Strong Buy | Reiterates | $12 | +183.69% | Mar 18, 2025 |
| Citizens Capital Markets | Citizens Capital Markets | Buy Reiterates $25 | Buy | Reiterates | $25 | +491.02% | Mar 14, 2025 |
Financial Forecast
Revenue This Year
2.16K
from 20.00K
Decreased by -89.19%
Revenue Next Year
33.67M
from 2.16K
Increased by 1,557,547.82%
EPS This Year
-1.31
from -1.34
EPS Next Year
-1.61
from -1.31
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 15,750 | 210.0M | 135.1M | ||
| Avg | 2,161 | 33.7M | 33.5M | ||
| Low | n/a | n/a | n/a |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | -21.3% | 9,715,824.9% | 301.3% | ||
| Avg | -89.2% | 1,557,547.8% | -0.6% | ||
| Low | - | - | - |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | -1.07 | -1.44 | -0.78 | ||
| Avg | -1.31 | -1.61 | -1.26 | ||
| Low | -1.59 | -2.26 | -1.58 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | - | - | - | ||
| Avg | - | - | - | ||
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.